Lzhh-XL Cream contains luliconazole 1% w/w, an imidazole antifungal agent indicated for the topical treatment of superficial fungal infections such as dermatophytosis, tinea pedis, tinea cruris, and tinea corporis. Luliconazole exerts its antifungal effect by inhibiting the enzyme lanosterol 14α-demethylase, a key component in ergosterol biosynthesis, thereby disrupting fungal cell membrane synthesis and leading to fungal cell death. The cream formulation allows for effective penetration into the stratum corneum, providing targeted antifungal activity with minimal systemic absorption. Lzhh-XL Cream is typically applied once daily to the affected area and surrounding skin after cleansing and drying, with treatment duration varying depending on the infection type and severity, generally ranging from one to four weeks. It is well tolerated, with adverse effects such as mild local irritation or itching being infrequent. The product should be used with caution in patients with known hypersensitivity to luliconazole or any cream excipients. Lzhh-XL Cream offers a convenient and effective therapeutic option for managing superficial fungal infections, promoting rapid symptom relief and resolution of infection when used as directed under medical supervision.